Skip to content
JustPartnering
Custom Research Reports

Research that tells you what to do next.

JustPartnering produces custom, independent research that answers one specific decision in front of your team.

It might be whether a modality is competitive, which partners are in-licensing in your area, or whether your development plan matches what buyers need to see. Every report is quoted in writing before work starts.

A report built to answer one decision, not survey a market.

A custom research report draws on active partnering intelligence, proprietary data sources, and domain expertise to tell you what to do next for a specific decision, not just what the landscape looks like. We work on an hourly basis, with no retainers or minimum commitments, typically 15 to 40 hours per report.

Most market intelligence misses your real question.

Broad industry reports cover the landscape. They will not tell you whether your specific modality is competitive, which partners are actively in-licensing in your therapeutic area, or whether your development plan aligns with what buyers need to see.

Answering it takes people who understand both the science and the deal, not a market analyst working from public filings.

Why choose us

Built on active partnering work

We work in the partnering market ourselves, so we know what a buyer will ask.

We know what buyers want

We hold 300+ face-to-face partnering meetings a year, plus many more virtually. We know which companies are actively in-licensing, what data packages they want to see, and how they evaluate assets. That intelligence shapes every report we write.

Independent and objective

We have no stake in the asset or the institution behind it, and we aren’t paid on outcome, so the report tells you where the asset stands, including when the answer is unwelcome.

Scientific and commercial review in one team

Our team includes regulatory, CMC, and clinical specialists alongside BD advisors. When we assess a development pathway, we do it with an eye on what partners and investors need to see at each stage.

Deep domain networks

Where the analysis needs specialist input we do not hold in-house, we draw on a global network of trusted domain experts, brought in per project, briefed and managed by us.

Recent work

Recent reports prepared by our team

01

Mapping the global RNA pipeline for an investment decision

Challenge

An organisation needed to understand the breadth and maturity of the global pharma pipeline across RNA modalities before committing to an investment strategy.

Delivered

We gathered and synthesised a comprehensive dataset across clinical stages and companies, then structured the findings so the picture was clear at a glance.

Outcome

A report that directly shaped their capital allocation decisions.

02

Identifying high-value vaccine opportunities for an APAC developer

Challenge

A vaccine developer wanted to pinpoint the most commercially attractive opportunities aligned to their platform, region, and target population.

Delivered

We analysed epidemiology, market size, competitive activity, and unmet need across the full candidate set.

Outcome

A ranked shortlist of the strongest opportunities, with the reasoning for each.

03

Evaluating a combination therapy against the commercial landscape

Challenge

An organisation exploring a combination product needed an honest assessment of commercial viability.

Delivered

We mapped relevant monotherapies across routes of administration and indications, and identified the key differentiators and risks.

Outcome

Evidence-backed conclusions on whether, and how, the combination could compete.

Ready to commission a report?Book a discovery call
Our process

Structured analysis, typically delivered in two to four weeks

Every engagement starts with a scoping call to define the decision you need to make.

  1. 1

    Scoping call

    We clarify your objectives and the specific decision the research needs to support. This shapes the scope, so you only pay for what is relevant.

    Book a call
  2. 2

    Structured research

    Your question runs through the evaluation frameworks we use across client work, so the analysis starts from a tested structure rather than a blank page.

  3. 3

    Expert validation

    The team validates, interprets, and refines every output, adding context, commercial judgement, and domain input where needed. Nothing leaves without human sign-off.

  4. 4

    Polished report

    You receive a clear, presentation-ready report with findings, analysis, and recommended next steps, written around the decision you named at scoping.

What we cover

We tailor each report to your technology and the specific decision you need to make. Typical focus areas:

Commercial opportunity

Market segmentation and sizing for the specific opportunity in front of you.

Manufacturing feasibility

Scale-up pathways and manufacturing considerations, assessed early.

Competitive landscape

Direct competitors and adjacencies you need on the radar.

Development & regulatory pathway

Feasibility and route assessment across the markets that matter.

Technical & clinical differentiation

What sets the asset apart on the science and the data.

Partnering & licensing landscape

Who is actively in-licensing in your area, and what they expect to see.

Modality assessment

Comparison across modalities and platforms.

Commercial narrative & positioning

Early-stage positioning that stands up to partner scrutiny.

How we compare

An off-the-shelf market report, versus a JustPartnering custom report.

Off-the-shelf reportJustPartnering custom report
TurnaroundPublished on the vendor’s scheduleTwo to four weeks for focused analyses
CostFixed licence feeHourly; most focused reports run 15–40 hours
Track record

The partnering work behind every report.

50+
Assets progressed from lab to clinic
19+
Years of partnering experience

Common questions

What makes your research reports different from a commercial market report?
Commercial market reports cover broad industries or therapeutic categories. Our reports are built around a specific asset, platform, or decision. We draw on active partnering intelligence, proprietary data sources, and domain expertise to answer the question you are actually asking, not a generalised version of it.
What data sources do you use?
We draw from GlobalData, Biocontacts, scientific literature, regulatory databases, and internal datasets built through our active partnering work. Our proprietary Biocontacts database tracks in-licensing interests across more than 2,500 life sciences companies.
How long does a report take to produce?
Scope determines timeline. A focused competitive landscape or partnering analysis typically takes two to four weeks from scoping call to delivery. More complex, multi-topic reports may take six to eight weeks. We give you a clear estimate before work begins.
How much does a custom research report cost?
Pricing depends on scope and complexity. We charge on an hourly basis, with no retainers, no mark-ups, and no minimum commitment. After a brief scoping conversation, we send a written estimate with an hour range and expected timeline. Most focused reports fall in the range of 15 to 40 hours.
Can you combine research with advisory support?
Yes. Some clients engage us to produce a research report as a standalone deliverable. Others use it as the foundation for a broader BD or licensing engagement, using the findings to inform partner targeting, positioning, or development planning. We can scope it either way.
Do you work across all therapeutic areas?
Our core experience spans oncology, rare disease, CNS, infectious disease, immunology, and animal health, with expertise across all modalities, including RNA, vaccines, and cell and gene therapy. For areas that need deep specialist input, we bring in domain experts from our global network at no additional cost to you.

Have a decision that needs real answers?

Start with a free 30-minute discovery call. We will scope it and give you an honest estimate.

Book a discovery call